HAS2 and neoplasm: Finally, in multiple breast cancerdatasets, high levels of ESRP1, ESRP1/HAS2, and ESRP1/ZEB1 correlate with poorprognosis, supporting the relevance of ZEB1/ESRP1 and ZEB1/HAS2 axes in tumorprogression.